ArticleArchives of medical science : AMS2025
Unveiling the immune-related ceRNA network in osteoarthritis: key biomarkers and therapeutic targets.
Article in Archives of medical science : AMS, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: The aim of this study was to explore the immune-related competitive endogenous RNA (ceRNA) network in osteoarthritis (OA), focusing on identifying differentially expressed long non-coding RNAs (lncRNAs), constructing a classification model, and examining the associations between these lncRNAs and immune cell subsets in OA. Material and methods: Microarray data from the Gene Expression Omnibus (GEO) database were used to identify differentially expressed genes (DEGs) in synovial tissue of OA patients. A classification model was constructed using the Least Absolute Shrinkage and Selection Operator (LASSO) regression with selected lncRNAs. Computational methods such as CIBERSORT were employed to quantify immune cell infiltration patterns, and weighted gene co-expression network analysis (WGCNA) was conducted to delineate co-expression modules. Finally, a ceRNA network was constructed to elucidate the regulatory interactions among lncRNAs, miRNAs, and mRNAs. Results: We identified 5927 DEGs, among which 47 were differentially expressed long non-coding RNAs (DELs). Seven DELs (DGCR11, FAM215A, HCG9, PART1, FAM106A, NOP14-AS1, PRORY) formed the basis of a classification model with an area under the receiver operating characteristic (ROC) curve of 1. We also examined the infiltration patterns of immune cells in OA tissues and found significant differences compared to healthy controls, indicating a strong immunological component in OA pathogenesis. WGCNA identified a turquoise module showing a strong correlation with OA traits. Conclusions: The study highlights the importance of ceRNA networks in understanding the complex pathogenesis of OA and offers a comprehensive framework for future research into potential diagnostic biomarkers and therapeutic targets.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.